ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Study |
Article Title |
Endoscopic debulking resection with additive chemoradiotherapy: Optimal management of advanced inoperable esophageal squamous cell carcinoma
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Li-Hua Ren, Ye Zhu, Rong Chen, Mulmi Shrestha Sachin, Qin Lu, Wei-Hua Xie, Tong Lu, Xiao-Ying Wei and Rui-Hua Shi |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Fundamental Research Funds for the Central Universities, Postgraduate Research and Practice Innovation Program of Jiangsu Province |
KYCX19_0118 |
Jiangsu Science and Technology Project, Innovative Team Project of Esophagus |
2017ZXK7QW08 |
National Natural Science Foundation of China |
81570503 |
|
Corresponding Author |
Rui-Hua Shi, MD, PhD, Additional Professor, Department of Gastroenterology, Zhongda Hospital, School of Medicine, Southeast University, No. 87 Dingjiaqiao Road, Nanjing 210009, Jiangsu Province, China. ruihuashi@126.com |
Key Words |
Esophageal squamous cell carcinoma; Endoscopic resection; Chemoradiotherapy; Overall survival; Progression-free survival |
Core Tip |
Forty-one advanced esophageal squamous cell carcinoma (ESCC) patients were retrospectively enrolled, including 28 patients who underwent endoscopic debulking resection (EdR) plus chemoradiotherapy (CRT) and 13 who received EdR without CRT. Clinicopathological characteristics, perioperative outcomes, cumulative overall survival (OS), and progression-free survival (PFS) rates were analyzed. Our results confirm that EdR is safe and feasible for advanced ESCC patients and that EdR + CRT showed better OS and PFS than EdR alone. |
Publish Date |
2022-09-09 12:48 |
Citation |
Ren LH, Zhu Y, Chen R, Shrestha Sachin M, Lu Q, Xie WH, Lu T, Wei XY, Shi RH. Endoscopic debulking resection with additive chemoradiotherapy: Optimal management of advanced inoperable esophageal squamous cell carcinoma. World J Gastrointest Oncol 2022; 14(9): 1758-1770 |
URL |
https://www.wjgnet.com/1948-5204/full/v14/i9/1758.htm |
DOI |
https://dx.doi.org/10.4251/wjgo.v14.i9.1758 |